Iambic Therapeutics files for US IPO
Iambic Therapeutics filed for an initial public offering in the US on Monday.
Story updates
08:40:36 PM UTC
SquawkNews
Iambic Therapeutics filed for an initial public offering on the Nasdaq Global Select Market under the ticker “IAM.” The AI-native biopharma integrates proprietary large-scale AI with automated chemistry and biology to design and advance small-molecule drugs. Proceeds are earmarked to progress lead…
08:47:24 PM UTC
SquawkNews
By Katherine HamiltonIambic Therapeutics filed for an initial public offering.The clinical-stage life sciences company plans to trade on Nasdaq under the ticker IAM. It didn't disclose the pricing or amount of shares it plans to offer, according to a Securities and Exchange Commission filing on Mon…